세계의 공간 유전체학 및 전사체학 시장 예측(-2029년) : 제품별, 기법별, 서비스 유형별, 용도별
Spatial Genomics & Transcriptomics Market by Product (Instruments, Consumables, Services), Technique(Transcriptomics (IHC, ISH), Genomics (LCM)), Service Type(Sample Prep, Sequencing), Application (Translation Research (Cancer))-Global Forecast to 2029
상품코드:1635138
리서치사:MarketsandMarkets
발행일:2025년 01월
페이지 정보:영문 450 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 공간 유전체학·전사체학 제품 시장 규모는 2024년 5억 5,450만 달러에서 2029년까지 9억 9,570만 달러에 달할 것으로 예측되며, 예측 기간에 CAGR로 12.4%의 성장이 전망됩니다.
조사 범위
조사 대상연도
2022-2029년
기준연도
2023년
예측 기간
2024-2029년
단위
달러
부문
제공, 기법, 용도, 유형(서비스), 최종사용자(제품), 최종사용자(서비스)
대상 지역
북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카
공간유전체-트랜스스크립틱스 시장은 신제품의 도입과 신약개발 및 의약품 개발에서 공간유전체-트랜스스크립틱스의 수용 확대 등의 요인에 영향을 받아 성장하고 있습니다. 하지만 고가의 초기 자본 투입, 기술적 복잡성, 지식 격차 등이 산업계에 다양한 어려움을 야기하고 있습니다.
"제품별로는 제품 부문이 2023년 시장에서 가장 큰 점유율을 차지했습니다."
제품 부문이 2023년 가장 큰 점유율을 차지했습니다. 연구 분야에서 고해상도 공간 유전자 및 단백질 발현 데이터에 대한 수요 증가가 이 부문의 성장을 설명하는 데 도움이 될 것입니다. 시장 확대의 주요 촉진요인은 제약 연구 및 개발에서 소모품 및 공간 유전체학/트랜스스크립틱스의 적용 확대와 바이오마케터 발굴이 주요 성장 요인으로 꼽힙니다. 이 시장 부문의 주요 성장 촉진요인은 시장 진출기업이 특히 공간 분석 및 신제품 도입을 위한 다양한 소프트웨어 개발에 대한 투자를 늘리고 있다는 점입니다.
"기술별로는 공간 트랜스크립션 기법이 22023년 가장 높은 시장 점유율을 차지했습니다."
in situ 시퀀싱 기술의 수용이 확대되고 질병 연구에 보다 종합적으로 활용됨에 따라 공간 전사체학 부문은 2023년 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다. 공간 전사체학을 통해 조직의 공간적 맥락에서 유전자 발현을 매핑할 수 있습니다. 조직학 및 분자 데이터를 결합하여 특정 조직 영역에서 유전자가 어떻게 발현되는지 밝혀내어 세포 조직, 기능, 질병 진행에 대한 이해를 돕습니다.
"아시아태평양은 2024-2029년 시장에서 가장 높은 CAGR로 성장할 것입니다."
아시아태평양은 의료 수요 증가에 대한 정부 활동 증가, 생명공학에 대한 정부 투자 증가, 정밀의료에 대한 수요 증가, 의료비 증가, 인도, 중국, 일본 등 주요 시장에서의 연구개발 확대, 양호한 규제 환경으로 인해 가장 빠르게 성장하는 시장이 될 것으로 예상됩니다. 될 것으로 추정됩니다. 한편, 북미는 2023년에 가장 큰 시장 점유율을 차지할 것으로 예상됩니다.
세계의 공간유전체학-트랜스스크립틱스(Space Genomics-Transcriptomics) 시장을 조사 분석했으며, 주요 촉진요인과 저해요인, 경쟁 구도, 향후 동향 등의 정보를 전해드립니다.
The spatial genomics & transcriptomics product market is expected to reach USD 995.7 million in 2029 from USD 554.5 million in 2024, at a CAGR of 12.4% during the forecast period.
Scope of the Report
Years Considered for the Study
2022-2029
Base Year
2023
Forecast Period
2024-2029
Units Considered
Value (USD)
Segments
Offering, Technique, Application, Type (Service), End User (Product), End User (Service)
Regions covered
North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
The spatial genomics and transcriptomics market is expanding under the influence of factors like new product introduction and rising acceptance of spatial genomics and transcriptomics in medication discovery and development. Nevertheless, expensive initial capital inputs and technical complexity and knowledge gap create various difficulties for the industry.
"The product segment accounted for the largest share by offering segment in the spatial genomics & transcriptomics market in 2023".
Products and services divide the spatial genomics & transcriptomics market. In 2023 the product segment held the biggest share. The growing demand for high-resolution spatial gene and protein expression data in research helps to explain the expansion of this area. The main forces behind the market expansion are the expanding uses of consumables and spatial genomics and transcriptomics in drug research and development as well as biomarketer identification. Key element driving development in this market segment is increased investments by market participants in creating various software especially for spatial analysis and introduction of new goods.
"The spatial transcriptomics technique held the highest market share of the spatial genomics and transcriptomics market by technique in 2023".
Techniques divide the spatial genomics and transcriptomics market into spatial transcriptomics and spatial genomics segments. Driven by growing acceptance of in situ sequencing technologies and more general applications in disease research, the segment of spatial transcriptomics held the biggest share of spatial genomics & transcriptomics market in 2023. Using spatial transcriptomics, one may map gene expression inside the spatial context of a tissue. Combining histology and molecular data reveals how genes are expressed in certain tissue country or region, so providing understanding of cellular organization, function, and disease progression.
"The Asia Pacific region is growing at the highest CAGR in the spatial genomics & transcriptomics market from 2024 to 2029."
The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the a
increasing government efforts to rising healthcare needs, growing government investment in
biotechnology, growing demand of precision medicine, rising healthcare expenditure, growing
R&D expansion in key markets such as India, China, and Japan, and the favorable regulatory
environment in the region. However, North America held the largest share of spatial genomics & transcriptomics market in 2023.
The primary interviews conducted for this report can be categorized as follows:
By Respondent: Supply Side- 60% and Demand Side 40%
By Designation: Managers - 45% CXOs and Director-level - 30%, and Executives - 25%,
By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.
List of Companies Profiled in the Report:
NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US)
10x Genomics (US)
Bio-Rad Laboratories, Inc. (US)
Illumina, Inc. (US)
Bio-Techne (US)
Seven Bridges Genomics (US)
Rarecyte, Inc. (US)
Standard BioTools (US)
Revvity (US)
Akoya Biosciences, Inc. (US)
Natera, Inc. (US)
VisioPharm A/S (Switzerland)
Danaher Corporation (US)
Veracyte, Inc. (US)
Biomarker Technologies (BMKGENE) (China)
Macrogen, Inc. (South Korea)
Miltenyi Biotec (Germany)
Sony Biotechnology Inc. (US)
Vizgen Inc. (US)
BioSpyder, Inc. (US)
Ionpath, Inc. (US)
S2 Genomics, Inc. (US)
Ultivue, Inc. (US)
Admera Health (US)
Lunaphore Technologies SA (US)
Visikol, Inc. (US)
Rebus Biosystems, Inc. (US)
Singular Genomics Systems, Inc. (US)
Cantata Bio (US)
Nucleai, Inc. (Israel)
Research Coverage:
This research report categorizes the spatial genomics & transcriptomics market by offering (products and services), by technique (spatial transcriptomics and spatial genomics), by type (service) (sample preparation services, sequencing & analytical services, and data visualization & analysis services), by application (translational research and drug discovery & development), by end user (product) (pharmaceutical & biotechnology companies, academic & research institutes, CROs & CDMOs, and clinical diagnostic laboratories), by end user (service) (pharmaceutical & biotechnology companies, academic & research institutes, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the spatial genomics & transcriptomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as product & service launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the spatial genomics & transcriptomics market. Competitive analysis of top players and upcoming startups in the spatial genomics & transcriptomics market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall spatial genomics & transcriptomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
Analysis of key drivers (Increasing adoption of spatial genomics and transcriptomics in drug discovery and development, Introduction of novel products, Increasing pharmaceutical R&D investments and public-private funding), restraints (High initial capital investments and maintenance costs, Technical complexity and expertise gap), opportunities (Increasing use of spatial omics for biomarker identification, Increasing demand for precision medicines and targeted drug development), and challenges (Dearth of skilled professionals) influencing the growth of the market.
Product Development/Innovation: Detailed insights on newly launched product/services of the spatial genomics & transcriptomics market
Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions.
Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the spatial genomics & transcriptomics market
Competitive Assessment: NanoString Technologies, Inc. (Bruker Spatial Biology, Inc.) (US), 10x Genomics (US), Bio-Rad Laboratories, Inc. (US), Illumina, Inc. (US), Bio-Techne (US), Seven Bridges Genomics (US), Rarecyte, Inc. (US), Standard BioTools (US), Revvity (US), Akoya Biosciences, Inc. (US), Natera, Inc. (US), VisioPharm A/S (Switzerland), Danaher Corporation (US), Veracyte, Inc. (US), Biomarker Technologies (BMKGENE) (China), Macrogen, Inc. (South Korea), Miltenyi Biotec (Germany), Sony Biotechnology Inc. (US), Vizgen Inc. (US), BioSpyder, Inc. (US), Ionpath, Inc. (US), S2 Genomics, Inc. (US), Ultivue, Inc. (US), Admera Health (US), Lunaphore Technologies SA (US), Visikol, Inc. (US), Rebus Biosystems, Inc. (US), Singular Genomics Systems, Inc. (US), Cantata Bio (US), and Nucleai, Inc. (Israel).
